Continuous dengue type 1 virus genotype shifts followed by co-circulation, clade shifts and subsequent disappearance in Surabaya, Indonesia, 2008-2013

Infection, Genetics and Evolution

Volumn 28, Issue , 2014, Pages 48-54

  Kotaki, Tomohiro ^a,b   Yamanaka, Atsushi ^a,c,d   Mulyatno, Kris Cahyo ^a   Churrotin, Siti ^a   Labiqah, Amaliah ^a   Sucipto, Teguh Hari ^a   Soegijanto, Soegeng ^a   Kameoka, Masanori ^b,e   Konishi, Eiji ^b,c,d  

^a AIRLANGGA UNIVERSITY   (Indonesia)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MAHIDOL UNIVERSITY   (Thailand)

^d OSAKA UNIVERSITY   (Japan)

^e KOBE UNIVERSITY   (Japan)

Author keywords

Clade shift; Co circulation; Dengue virus; Genotype shift; Indonesia; Phylogeny

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; DENGUE VIRUS 1; EPIDEMIOLOGICAL DATA; GENOTYPE; HUMAN; INDONESIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POPULATION DYNAMICS; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; VIRUS ENVELOPE; VIRUS ISOLATION; VIRUS STRAIN; CHEMISTRY; DENGUE; DENGUE VIRUS; GENETIC VARIABILITY; GENETICS; HISTORY; MOLECULAR GENETICS; SEROTYPE; VIROLOGY;

VIRUS PROTEIN; VIRUS RNA;

DENGUE; DENGUE VIRUS; GENETIC VARIATION; GENOTYPE; HISTORY, 21ST CENTURY; HUMANS; INDONESIA; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, VIRAL; SEROGROUP; VIRAL PROTEINS;

EID: 84907466746     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.09.002     Document Type: Article

References (57)

1. Aaskov J.G., Geysen H.M., Mason T.J. Serologically defined linear epitopes in the envelope protein of dengue 2 (Jamaica strain 1409). Arch. Virol. 1989, 105:209-211.
2. Andraud M., Hens N., Marais C., Beutels P. Dynamic epidemiological models for dengue transmission: a systematic review of structural approaches. PLoS One 2012, 7:e49085.
3. Araújo J.M., Nogueira R.M., Schatzmayr H.G., Zanotto P.M., Bello G. Phylogeography and evolutionary history of dengue virus type 3. Infect. Genet. Evol. 2009, 9:716-725.
4. Aryati, 2006. Moleculer Epidemiology of Dengue Virus in Indonesia (Dissertations). Airlangga University, Surabaya. (in Indonesian).
5. Brien J.D., Austin S.K., Sukupolvi-Petty S., O'Brien K.M., Johnson S., Fremont D.H., Diamond M.S. Genotype specific neutralization and protection by antibodies against dengue virus type 3. J. Virol. 2010, 84:10630-10643.
6. Chen R., Vasilakis N. Dengue - quo tu et quo vadis?. Viruses 2011, 3:1562-1608.
7. Crill W.D., Roehrig J.T. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 2001, 75:7769-7773.
8. Cummings D.A., Schwartz I.B., Billings L., Shaw L.B., Burke D.S. Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:15259-15264.
9. de Alwis R., Smith S.A., Olivarez N.P., Messer W.B., Huynh J.P., Wahala W.M., White L.J., Diamond M.S., Baric R.S., Crowe J.E., de Silva A.M. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:7439-7444.
10. Drummond A.J., Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 2007, 7:214.
11. Fahri S., Yohan B., Trimarsanto H., Sayono S., Hadisaputro S., Dharmana E., Syafruddin D., Sasmono R.T. Molecular surveillance of dengue in Semarang, Indonesia revealed the circulation of an old genotype of dengue virus serotype-1. PLoS Negl. Trop. Dis. 2013, 7:e2354.
12. Ferguson N., Anderson R., Gupta S. The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:790-794.
13. Fibriansah G., Tan J.L., Smith S.A., de Alwis A.R., Ng T.S., Kostyuchenko V.A., Ibarra K.D., Wang J., Harris E., de Silva A., Crowe J.E., Lok S.M. A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. EMBO Mol. Med. 2014, 6:358-371.
14. Goncalvez A.P., Escalante A.A., Pujol F.H., Ludert J.E., Tovar D., Salas R.A., Liprandi F. Diversity and evolution of the envelope gene of dengue virus type 1. Virology 2002, 303:110-119.
15. Gubler D.J. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 1988, 11:480-496.
16. Halstead S.B., O'Rourke E.J. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 1977, 265:739-741.
17. Halstead S.B. Dengue. Lancet 2007, 370:1644-1652.
18. Halstead S.B. Dengue virus-mosquito interactions. Annu. Rev. Entomol. 2008, 53:273-291.
19. Heinz F.X., Stiasny K. Flaviviruses and their antigenic structure. J. Clin. Virol. 2012, 55:289-295.
20. Hotta S. Experimental studies on dengue I. Isolation, identification and modification of the virus. J. Infect. Dis. 1952, 90:1-9.
21. Jiang T., Yu X.D., Hong W.X., Zhou W.Z., Yu M., Deng Y.Q., Zhu S.Y., Qin E.D., Wang J., Qin C.F., Zhang F.C. Co-circulation of two genotypes of dengue virus serotype 3 in Guangzhou, China, 2009. Virol. J. 2012, 9:125.
22. Khan E., Hasan R., Mehraj V., Nasir A., Siddiqui J., Hewson R. Co-circulations of two genotypes of dengue virus in 2006 out-break of dengue hemorrhagic fever in Karachi, Pakistan. J. Clin. Virol. 2008, 43:176-179.
23. Kimura R., Hotta S. Studies on dengue fever (VI). On the inoculation of dengue virus into mice. Nippon Igaku 1944, 3379:629-633.
24. Konishi E., Tabuchi Y., Yamanaka A. A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells. J. Virol. Methods 2010, 163:360-367.
25. Kotaki T., Yamanaka A., Mulyatno K.C., Labiqah A., Sucipto T.H., Churrotin S., Soegijanto S., Konishi E., Kameoka M. Phylogenetic analysis of dengue virus type 3 strains primarily isolated in Surabaya, Indonesia, in 2013. Jpn. J. Infect. Dis. 2014, 67:227-229.
26. Lai C.Y., Tsai W.Y., Lin S.R., Kao C.L., Hu H.P., King C.C., Wu H.C., Chang G.J., Wang W.K. Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J. Virol. 2008, 82:6631-6643.
27. Lanciotti R.S., Calisher C.H., Gubler D.J., Chang G.J., Vorndam A.V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 1992, 30:545-551.
28. Li D.S., Liu W., Guigon A., Mostyn C., Grant R., Aaskov J. Rapid displacement of dengue virus type 1 by type 4, Pacific region, 2007-2009. Emerg. Infect. Dis. 2010, 16:123-125.
29. Messer W.B., de Alwis R., Yount B.L., Royal S.R., Huynh J.P., Smith S.A., Crowe J.E., Doranz B.J., Kahle K.M., Pfaff J.M., White L.J., Sariol C.A., de Silva A.M., Baric R.S. Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:1939-1944.
30. Modis Y., Ogata S., Clements D., Harrison S.C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:6986-6991.
31. Montoya M., Gresh L., Mercado J.C., Williams K.L., Vargas M.J., Gutierrez G., Kuan G., Gordon A., Balmaseda A., Harris E. Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl. Trop. Dis. 2013, 7:e2357.
32. Mulyatno K.C., Yamanaka A., Yotopranoto S., Konishi E. Vertical transmission of dengue virus in Aedes aegypti collected in Surabaya, Indonesia, during 2008-2011. Jpn. J. Infect. Dis. 2012, 65:274-276.
33. Myat Thu H., Lowry K., Jiang L., Hlaing T., Holmes E.C., Aaskov J. Lineage extinction and replacement in dengue type 1 virus populations are due to stochastic events rather than to natural selection. Virology 2005, 336:163-172.
34. Olkowski S., Forshey B.M., Morrison A.C., Rocha C., Vilcarromero S., Halsey E.S., Kochel T.J., Scott T.W., Stoddard S.T. Reduced risk of disease during postsecondary dengue virus infections. J. Infect. Dis. 2013, 208:1026-1033.
35. Pierson T.C., Xu Q., Nelson S., Oliphant T., Nybakken G.E., Fremont D.H., Diamond M.S. The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host Microbe 2007, 1:135-145.
36. Rabaa M.A., Simmons C.P., Fox A., Le M.Q., Nguyen T.T., Le H.Y., Gibbons R.V., Nguyen X.T., Holmes E.C., Aaskov J.G. Dengue virus in sub-tropical northern and central Viet Nam: population immunity and climate shape patterns of viral invasion and maintenance. PLoS Negl. Trop. Dis. 2013, 7:e2581.
37. Roehrig J.T., Johnson A.J., Hunt A.R., Bolin R.A., Chu M.C. Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology 1990, 177:668-675.
38. Rothman A.L. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol. 2011, 11:532-543.
39. Sabin A.B. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1952, 1:30-50.
40. Setiati T.E., Wagenaar J.F.P., de Kruif M.D., Mairuhu A.T.A., van Gorp E.C.M., Augustinus S. Changing epidemiology of dengue haemorrhagic fever in Indonesia. Dengue Bull. 2006, 30:1-14.
41. Shrestha B., Brien J.D., Sukupolvi-Petty S., Austin S.K., Edeling M.A., Kim T., O'Brien K.M., Nelson C.A., Johnson S., Fremont D.H., Diamond M.S. The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog. 2010, 6:e1000823.
42. Sukupolvi-Petty S., Austin S.K., Engle M., Brien J.D., Dowd K.A., Williams K.L., Johnson S., Rico-Hesse R., Harris E., Pierson T.C., Fremont D.H., Diamond M.S. Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J. Virol. 2010, 84:9227-9239.
43. Sukupolvi-Petty S., Brien J.D., Austin S.K., Shrestha B., Swayne S., Kahle K., Doranz B.J., Johnson S., Pierson T.C., Fremont D.H., Diamond M.S. Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection. J. Virol. 2013, 87:8826-8842.
44. Suwandono A., Kosasih H., Nurhayati, Kusriastuti R., Harun S., Ma'roef C., Wuryadi S., Herianto B., Yuwono D., Porter K.R., Beckett C.G., Blair P.J. Four dengue virus serotypes found circulating during an outbreak of dengue fever and dengue haemorrhagic fever in Jakarta, Indonesia, during 2004. Trans. R. Soc. Trop. Med. Hyg. 2006, 100:855-862.
45. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28:2731-2739.
46. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., Endy T.P., Raengsakulrach B., Rothman A.L., Ennis F.A., Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 2000, 181:2-9.
47. Villabona-Arenas C.J., Zanotto P.M. Evolutionary history of dengue virus type 4: insights into genotype phylodynamics. Infect. Genet. Evol. 2011, 11:878-885.
48. Villabona-Arenas C.J., Zanotto P.M. Worldwide spread of dengue virus type 1. PLoS One 2013, 8:e62649.
49. Wahala W.M., Silva A.M. The human antibody response to dengue virus infection. Viruses 2011, 3:2374-2395.
50. Weaver S.C. Host range, amplification and arboviral disease emergence. Arch. Virol. Suppl. 2005, 19:33-44.
51. Weaver S.C., Vasilakis N. Molecular evolution of dengue viruses: contribution of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infect. Genet. Evol. 2009, 9:523-540.
52. Wikramaratna P.S., Simmons C.P., Gupta S., Recker M. The effects of tertiary and quaternary infections on the epidemiology of dengue. PLoS One 2010, 5:e12347.
53. Williams K.L., Wahala W.M., Orozco S., de Silva A.M., Harris E. Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo. Virology 2012, 429:12-20.
54. World Health Organization (WHO), 2012. Handbook of clinical management of dengue. Available: (08.05.2014). http://www.who.int/denguecontrol/9789241504713/en/.
55. World Meteorological Organization. Available: (08.05.2014). http://worldweather.wmo.int/en/city.html?cityId=648.
56. Yamanaka A., Mulyatno K.C., Susilowati H., Hendrianto E., Ginting A.P., Sary D.D., Rantam F.A., Soegijanto S., Konishi E. Displacement of the predominant dengue virus from type 2 to type 1 with a subsequent genotype shift from IV to I in Surabaya, Indonesia 2008-2010. PLoS One 2011, 6:e27322.
57. Zhang C., Mammen M.P., Chinnawirotpisan P., Klungthong C., Rodpradit P., Monkongdee P., Nimmannitya S., Kalayanarooj S., Holmes E.C. Clade replacements in dengue virus serotypes 1 and 3 are associated with changing serotype prevalence. J. Virol. 2005, 79:15123-15130.